3
Announcements
Trials
Browse
Landscape
Phase
Phase EARLY_PHASE1
1
Status
Terminated
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
8
Gynecologic
4
Thoracic
1
Other solid neoplasm
1
Genitourinary
1
Gastrointestinal
1
Conditions
Mesothelioma, Malignant
7
Unspecified Adult Solid Tumor, Protocol Specific
5
Retinoblastoma
3
Solid Tumors
2
Sarcoma
2
Mesothelioma
2
Thyroid Neoplasms
1
Thyroid Carcinoma, Anaplastic
1
Thyroid Cancer, Papillary
1
Stomach Neoplasms
1
Solid Tumours
1
Solid Tumor
1
Small Cell Lung Carcinoma
1
Rhabdomyosarcoma
1
Retinal Neoplasms
1
Rectal Neoplasms
1
Pseudomyxoma Peritonei
1
Pheochromocytoma
1
Peritoneal Neoplasms
1
Pelvic Neoplasms
1
Ovarian Neoplasms
1
Optic Nerve Glioma
1
Oligodendroglioma
1
Neoplasm Metastasis
1
Medulloblastoma
1
Lung Neoplasms
1
Liver Neoplasms
1
Liposarcoma
1
Head and Neck Neoplasms
1
HER2-negative Breast Cancer
1
Interventions
Thiotepa
2
Filgrastim
2
tazemetostat
1
sodium thiosulfate
1
pembrolizumab
1
X-Rays
1
Topotecan
1
Specimen Handling
1
Platinum
1
Peripheral Blood Stem Cell Transplantation
1
Melphalan
1
Magnetic Resonance Spectroscopy
1
Immunologic Techniques
1
Hyperthermic Intraperitoneal Chemotherapy
1
Granulocyte Colony-Stimulating Factor
1
Doxorubicin
1
Cytoreduction Surgical Procedures
1
Cisplatin
1
Carboplatin
1
Busulfan
1
Bone Marrow Transplantation
1
Arsenic Trioxide
1
Amifostine
1
1,2-diaminocyclohexaneplatinum II citrate
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Desmoplastic Small Round Cell Tumor
×
Doxorubicin
×
Other solid neoplasm
×
Clear all
NCT04213794
2025-02-20
TOASTIT
Mayo Clinic
Phase EARLY_PHASE1
Terminated
2 enrolled